Fig. 1From: Augmentation of histone deacetylase 3 (HDAC3) epigenetic signature at the interface of proinflammation and insulin resistance in patients with type 2 diabetesGlobal HDAC activity in PBMCs from control (NGT) subjects and type 2 diabetes mellitus (T2DM) patients. Bars represent the mean ± SEM, *p < 0.001 compared to control subjectsBack to article page